Skip to main content
Caplight Logo









MedCu

MedCu

Private
HerzliyaHealthcare & Life Scienceshttps://medcu.com

Last Round

Grant

Nov 24, 2025

Total Funding Raised

$25,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MedCu operates in Healthcare & Life Sciences and is based in Herzliya. Its latest recorded funding round was a Grant round in November 2025.

MedCu is a medical supplies company that manufactures advanced wound healing dressings intended to address chronic and acute hard-to-heal wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MedCu Comparables

Compare MedCu with similar companies based on industry and business-model similarity.

MedCu comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanordica Medical
86%
ConvaTec Group PLC
77%
Covalon Technologies Ltd.
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MedCu Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 24, 2025
Early FundingNov 11, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Shiri Turjeman

COO (Chief Operations Officer)

Executive Team

For institutional investors. Book with your work email.

MedCu Investors

Notable investors and investment history

MedCu investors
InvestorRounds
MedTech InnovatorGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 63% MoM.

  • Jan 25, 2026

    Monthly visitors increased 733% MoM, reaching 6.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

MedCu Filings

Explore SEC and related filing metadata, where available.

MedCu filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MedCu's valuation, stock price, and market status.

Is MedCu a public or private company?

MedCu is a private company.

What is the current stock price of MedCu?

MedCu is a private company, so its shares have no public market price. Caplight tracks MedCu's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MedCu worth (valuation)?

Valuation information for MedCu is not publicly available.

Can I buy MedCu stock?

MedCu shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MedCu's last funding round?

MedCu's most recent funding round was Grant on November 24, 2025.

Who are the main investors in MedCu?

Key investors in MedCu include MedTech Innovator.

Will MedCu IPO soon?

No public IPO plans have been announced for MedCu.

How can I track MedCu secondary market activity?

Caplight tracks bids, offers, and trades in MedCu's shares on secondary markets.

Firmographic Details

HeadquartersHerzliya
Employee Range11
Year Founded2016
Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?